Events

Janssen Labs
Time: 8:00AM – 11:00AM
Location: LabCentral Lobby

RSVP after requesting the LabCentral code for free entry from Krista

Janssen Labs, the Johnson & Johnson Innovation Center in Boston and the Janssen Biotechnology Center of Excellence invite you to an in-depth look into the process of filing a biologic Investigational New Drug (IND) application and the procedures necessary for advancing your company's early-stage drug development program. Whether your goal is to develop a pipeline through commercial launch, or partner as early as possible, submitting an IND is a critical early milestone for every biotech company. With big Pharma and VC firms competing for the most promising compounds, startups are expected to demonstrate a solid plan for achieving IND acceptance. Join us for a series of short presentations exploring the basic requirements and considerations necessary to achieve a successful biologic IND submission. Please see RSVP for more details.